Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
39,000,391
-
Shares change
-
+130,477
-
Total reported value, excl. options
-
$50,727,151
-
Value change
-
+$146,680
-
Put/Call ratio
-
61.2%
-
Number of buys
-
35
-
Number of sells
-
-20
-
Price
-
$1.30
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q4 2016
91 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q4 2016.
TRANSENTERIX INC - COM NEW (TRXC) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,000,391 shares
.
Largest 10 shareholders include Aisling Capital LLC (8,335,819 shares), SV Life Sciences Advisers, LLC (7,546,692 shares), JPMORGAN CHASE & CO (4,230,205 shares), StepStone Group LP (3,032,625 shares), VANGUARD GROUP INC (2,375,330 shares), BlackRock Fund Advisors (2,244,578 shares), MASTERS CAPITAL MANAGEMENT LLC (1,898,825 shares), BlackRock Institutional Trust Company, N.A. (1,122,793 shares), AQR CAPITAL MANAGEMENT LLC (958,928 shares), and INTERNATIONAL BIOTECHNOLOGY TRUST PLC (889,082 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.